Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immediate Results and Six-Month Outcomes After Percutaneous Coronary Intervention in a Referral Heart Center in Isfahan, Iran



Khosravi A1 ; Pourmoghaddas M2 ; Asadi K1 ; Abdi A1 ; Gholamrezaei A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: ARYA Atherosclerosis Published:2011

Abstract

BACKGROUND: There is a lack of data in our society on the outcomes, complications, and prognostic factors in patients with coronary artery disease who underwent percutaneous coronary intervention (PCI). We evaluated the success rate, early and late outcomes, and prognostic factors in a referral university center in Isfahan, IRAN. METHODS: This prospective cohort study was conducted in Chamran University Hospital in Isfahan (IRAN) from March 2010 to February 2011. Patients consequently were included if they have the indication for emergent or elective PCI. Outcomes included procedural success, complications, and major adverse cardiovascular events (MACE) during hospitalization and 6 months follow-up. RESULTS: A total of 282 patients (74.1% females) with mean age of 57.0±3.2 years were studied. Most of the patients (89.7%) underwent elective PCI. Angiographic and procedure success rates were 95.7% and 94.6%, respectively. In-hospital MACE included two cases of death (0.7%) and one MI (0.3%); 2/29 (6.9%) of the emergent PCI and 1/253 (0.4%) of the elective PCI cases. MACE during follow-up included three cases of death (1.0%) and two MI (0.7%); 2/252 (0.8%) of the elective PCI and 1/28 (3.5%) of the emergent PCI cases. The overall MACE was calculated as 8 cases (2.8%) which included 5/29 (17.2%) of the emergent and 3/253 (1.1%) of the elective cases; P < 0.001. In multivariate analysis, none of the factors including gender, age, emergency of the procedure, lesion type, number of stenotic vessels, or stent type were associated with total MACE (P > 0.05). CONCLUSION: PCI is performed with an acceptable success rate in our center in Isfahan and mortality and complications are within the range reported by other highly specialized centers in IRAN. Further studies with larger sample size are needed to find predictive factors.
Related Docs
View other Related Docs
1. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
2. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
3. Background and Design of a 5-Year St Elevation Myocardial Infarction Cohort in Isfahan, Iran: Semi-Ci Study, ARYA Atherosclerosis (2022)
4. Clinical, Laboratory, and Procedural Predictors of Slow Flow/No Reflow Phenomenon After Emergency Percutaneous Coronary Interventions in St-Elevated Myocardial Infarction, Egyptian Heart Journal (2024)
5. Long-Term Outcome and Prognostic Value of Angiographic Slow/No-Reflow Phenomenon After Emergency Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction, Coronary Artery Disease (2024)
6. Clinical Characteristics, Management and 1-Year Outcomes of Patients With Acute Coronary Syndrome in Iran: The Iranian Project for Assessment of Coronary Events 2 (Ipace2), BMJ Open (2015)
7. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
8. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
Experts (# of related papers)
View all Related Experts
Masoumeh Sadeghi (55)
Nizal Sarrafzadegan (49)
Other Related Docs
9. Medical Therapy Versus Percutaneous Coronary Intervention or Coronary Artery Bypass Graft in Stable Coronary Artery Disease; a Systematic Review and Meta-Analysis of Randomized Clinical Trials, ARYA Atherosclerosis (2022)
10. Development of the First Iranian Clinical Practice Guidelines for the Diagnosis, Treatment, and Secondary Prevention of Acute Coronary Syndrome, Journal of Research in Medical Sciences (2024)
11. Analysis of Traditional Risk Factors on St-Segment Elevation Myocardial Infarction Characteristics; [بررسی عوامل خطر سنتی مرتبط با ویژگیهای بالینی بیماران انفارکتوس میوکارد با بالارونده قطعه St], Journal of Isfahan Medical School (2024)
12. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
13. Comparison of Survival Rate and Complications of Percutaneous Coronary Intervention, Coronary Artery Bypass Graft, and Medical Treatment in Patients With Left Main And/Or Three Vessel Diseases, ARYA Atherosclerosis (2020)
14. The Pattern of In-Hospital Mortality of Myocardial Infarction and Associated Factors in Iran: A National Study, Journal of Isfahan Medical School (2015)
15. The Five-Year Trend of Coronary Artery Diseases Based on Angiography Results in Central Part of Iran, Iranian Heart Journal (2012)
16. Cytochrome P450 2C19 Polymorphism in Iranian Patients With Coronary Artery Disease, ARYA Atherosclerosis (2011)
17. Utilization of Coronary Computed Tomography Angiography for Rapid Risk Stratification in Emergency Chest Pain Units, Journal of Research in Medical Sciences (2014)
18. Comparison of the One-Year Outcome Between Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease, Iranian Heart Journal (2022)
19. Predictors of Mortality for Patients With St-Elevation Myocardial Infraction After 2-Year Follow-Up: A St-Elevation Myocardial Infarction Cohort in Isfahan Study, Advanced Biomedical Research (2022)
20. Predicting Factors of Short-Term Survival in Patients With Acute Myocardial Infarction in Isfahan Using a Cox Regression Model, Iranian Journal of Epidemiology (2012)
21. Rationale, Design, and Preliminary Results of the Iran-Premature Coronary Artery Disease Study (I-Pad): A Multi-Center Case-Control Study of Different Iranian Ethnicities, ARYA Atherosclerosis (2020)
22. Evaluation of Coronary Angioplasty Results in Patients Referring to Isfahan Cardiac Centers, Iran, and Comparing With Clinical Guidelines, Journal of Isfahan Medical School (2017)
23. Trends of 28 Days Case Fatality Rate After First Acute Myocardial Infarction in Isfahan, Iran, From 2000 to 2009, ARYA Atherosclerosis (2015)
24. Fixed Dose Combination Therapy for Secondary Prevention of Major Cardiovascular Events: Review of Literature and Design for Persian Polypill, a Randomized Clinical Trial, Current Problems in Cardiology (2022)
25. Explaining the Decline in Coronary Heart Disease Mortality Rate Using Impact Model: Estimation of the Changes in Risk Factors and Treatment Uptake in Iran Between 2007 and 2016, ARYA Atherosclerosis (2023)
26. Care of Patients With St-Elevation Myocardial Infarction: An International Analysis of Quality Indicators in the Acute Coronary Syndrome Stemi Registry of the Eurobservational Research Programme and Acvc and Eapci Associations of the European Society of Cardiology in 11 462 Patients, European Heart Journal: Acute Cardiovascular Care (2023)
27. The Impact of Generic Form of Clopidogrel on Cardiovascular Events in Patients With Coronary Artery Stent: Results of the Opces Study, Journal of Research in Medical Sciences (2011)
28. Audit and Quality Assessment of National Persian Registry of Cardiovascular Disease(N-Prove) in Terms of Comorbidities, Angiography, and Angioplasty Characteristics in Iran, ARYA Atherosclerosis (2024)
29. Evaluating the Impact of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Lesions on the Mode of Treatment and Their Outcomes: An Iranian Experie, ARYA Atherosclerosis (2015)
30. Predictive Factors of Short-Term Survival From Acute Myocardial Infarction in Early and Late Patients in Isfahan and Najafabad, Iran, ARYA Atherosclerosis (2016)
31. The Role of Manual Thrombectomy in Cardiovascular Outcome Among Patients With Total Cutoff Vessel Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, ARYA Atherosclerosis (2017)
32. Determination of Characteristics and Data Elements Requirements in National Acute Coronary Syndrome Registries for Postdischarge Follow-Up, Current Problems in Cardiology (2023)
33. The Correlation Between Early Complications of Percutaneous Coronary Intervention and High Sensitive C-Reactive Protein, ARYA Atherosclerosis (2013)
34. The Comparison of Procedural and Clinical Outcomes of Thrombolytic-Facilitated and Primary Percutaneous Coronary Intervention in Patients With Acute St-Elevation Myocardial Infarction (Stemi): Findings From Prove/Acs Study, ARYA Atherosclerosis (2020)
35. Age at Menarche and Risk of Premature Coronary Artery Disease: Results From Iran Premature Coronary Disease (Ipad) Study, Archives of Gynecology and Obstetrics (2025)
36. Reperfusion Therapies and In-Hospital Outcomes for St-Elevation Myocardial Infarction in Europe: The Acvc-Eapci Eorp Stemi Registry of the European Society of Cardiology, European Heart Journal (2021)
37. A Cardiovascular Risk Assessment Model According to Behavioral, Psychosocial and Traditional Factors in Patients With St-Segment Elevation Myocardial Infarction (Cras-Mi): Review of Literature and Methodology of a Multi-Center Cohort Study, Current Problems in Cardiology (2023)
38. Cardiovascular Risk Factors and Clinical Outcomes Among Patients Hospitalized With Covid-19: Findings From the World Heart Federation Covid-19 Study, Global Heart (2022)
39. Long-Term Effects of Opium Consumption Following Percutaneous Coronary Intervention: A 10-Year Follow-Up Study, Global Heart (2024)
40. Comparison of No-Reflow Phenomenon After Percutaneous Coronary Intervention for Acute Myocardial Infarction Between Smokers and Nonsmokers, Journal of Research in Medical Sciences (2014)
41. Electrolyte Abnormalities in Hospitalized Covid-19 Patients at Tertiary Referral Centers in Tehran: Hypermagnesemia As a Marker of Fatality: A Retrospective Cross-Sectional Study, Health Science Reports (2023)
42. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
43. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
44. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
45. Risk Factors for In-Hospital Mortality Among Patients With Coronavirus-19 in Isfahan City, Iran, Advanced Biomedical Research (2022)
46. Evaluating the Relationship Between Rheumatic Valvular Heart Disease and Coronary Artery Diseases in Patient With Stable Angina in Isfahan City, Iran, Journal of Isfahan Medical School (2018)
47. Coronary Artery Calcification—Does It Predict the Cad-Rads Category?, Emergency Radiology (2022)
48. Prediction of Short-Term Clinical Outcome of Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Through Myeloperoxidase Levels, ARYA Atherosclerosis (2014)
49. Qt Dispersion and Age; Independent Predictors of Restenosis After Percutaneous Coronary Intervention, Reviews on Recent Clinical Trials (2017)
50. Estimation and Prediction of Mortality Rate Induced by Ischemic Heart Disease With Incomplete Data in Isfahan Using Age-Period-Cohort Analysis During 2004-2018, Journal of Health System Research (2019)